Open Access Open Access  Restricted Access Subscription or Fee Access

Formulation and Development of Ibuprofen Floating Tablet

Fathima Fabina, Syam Prasad PS, Fathima Hanan, Fathima PM, Dr.Ibrahim Afsal

Abstract


The investigation focused on optimizing a gastric floating drug delivery system (GFDDS) for Ibuprofen tablets. It employed polymers like HPMC K4M and Carbopol 940 to improve Ibuprofen's bioavailability and therapeutic effectiveness. GFDDS, with lower bulk density than gastric fluids, remains buoyant in the stomach, extending gastric residence time. Compatibility assessments, via DSC analysis, indicated harmony between the polymers used, with no observed interaction between the polymer and the drug. The study aimed to formulate and characterize sustained-release floating tablets of Ibuprofen, utilizing HPMCK4M and Carbopol 940 as the selected polymers. Through this method, researchers sought to enhance drug delivery, ensuring sustained release and prolonged residence in the stomach for improved therapeutic outcomes. The incorporation of these polymers in the formulation aimed to address challenges associated with conventional drug delivery systems, potentially offering a more effective means of administering Ibuprofen. This investigation underscores the importance of tailored drug delivery systems in optimizing drug performance and enhancing patient outcomes, particularly in cases where sustained release and prolonged gastric residence are advantageous.

Keywords


Ibuprofen, Buoyancy lag time, HPMCK4M, Carbopol 940, Polymer-based sustained release floating drug delivery.

Full Text:

PDF

References


Rouge N, Buri P and Doelker E. “Drug Absorption sites in the Gastrointestinal tract and dosage Forms for site specific delivery”, International journal of Pharmaceutics. 1996, 36, pp 117-139.

Soppimath KS, Kulkarni RA, RudzinskiWT and Aminabhavi TM.

“Microspheres as floating drug Delivery systems to increase gastric Retention ofdrugs”, Drug metabolism Reviews, 2001, 33, pp 149-160.

Singh BN and Kim KH. “Floating drug Delivery systems: an approach to oral Controlled drug delivery via gastric Retention”, Journal of Control Release, 2000, 63, pp 235-239.

www.niro.com/niro/cmsdoc.nsf/webdoc/ndkw67hhfv.

https://www.scribd.com/document/54511698/Microsoft-Word-Lecture-6-Cont-09-10

Vendruscolo CW, Andreazza IF, Ganter JL, Ferrero C and Bresolin TM. “Xanthan and galactomann matrix Tablets based for oral controlled Delivery of theophylline”, International journal of Pharmaceutics, 2005, 296, pp 1-11

Ziyaur R, Mushir A and Khar RK. “Design and Evaluation of bilayer Floating tablets of captopril”, ActaPharmaceutica, 2006, 56, pp 4957.

Reshu Gupta and kamala pathak. “Optimisation studies on floating Multiparticulate gastro retentiva drug Delivery system of famotidine”, Drug Development and industrial Pharmacy, 2008, pp 1201-1208.

Kumar, N. Sarath. "Aceclofenac floating tablets-a promising sustained release dosage form." Int J Drug Dev & Res 3.2 (2011): 290-300..

LuyPaert, zhang J and Massart M.H. “Feasibility study of the use of near Infrared spectroscopy in the Quantitative analysis of green. Tea,camelliasinesis(l.)”,AnalyticaChimicaActa, 2003, 478(2), pp 303-312.

Praneeth Kumar S. “Formulation and evaluation Of floating drug delivery of metoprolol Succinate”, Aapspharmsci tech, 2009, 1, pp 1-315. Int. J. Drug Dev. & Res., April-June 2011, 3 (2): 290-300

Controlled and novel drug delivery” by N.K.Jain. CBS Publications. Pg.no:256-257.

Controlled dug delivery concepts and Advances” by S.P.vyas, Roop K. Khar, Vallabhprakashan publishers. Pg.no:60-61.

BiopharMaceutics and pharmacokinetics” – a Treatise by D.M.Brahmankar, Sunil B. Jaiswal pg.no:398-399.

The Theory and practice of industrial Pharmacy” by Leon Lachmann 1986,


Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Research & Reviews: A Journal of Drug Design & Discovery